OUR STORY

My Gene Counsel was founded by the team that built and ran the Cancer Genetic Counseling Program at Yale School of Medicine and lead the field in publications on the rate of guideline changes and preventing errors in care.

In 2013, a sequence of events made the structural problem impossible to ignore. Angelina Jolie published her New York Times editorial disclosing she carried a BRCA1 mutation. Referrals to Yale increased 40 percent overnight and never returned to baseline — creating a nine-month waitlist for a non-urgent referral. Weeks later, the Supreme Court unanimously banned human gene patents. Within five hours, multiple laboratories were offering hereditary cancer panel testing at half the previous cost. And as testing expanded rapidly into primary care and oncology without genetic counseling support, patients across the country began receiving results they couldn’t understand — and providers had no infrastructure to help them.

The genomic ecosystem had become extraordinarily good at generating results. It had built almost no infrastructure for what happened after.

Our founders built My Gene Counsel to close that gap. My Gene Screen identifies the right patients for testing. Living Lab Reports® make every result immediately actionable. Genetic Alerts ensures that when the science changes — when a variant is reclassified, when guidelines are updated — no patient is left with outdated information. Together, the three tools form the activation layer that connects genomic findings to the ongoing clinical value they were always meant to generate.

My Gene Counsel is not a telemedicine company. We do not provide medical appointments, virtual consultations, or direct clinical care. We are a digital genetics platform that delivers the clinical expertise of board-certified genetic counselors through software — at a scale, and with a persistence over time, that no human workforce could match alone.